A variety of targeted anticancer agents have been successfully introduced into clinical
practice, largely reflecting their ability to inhibit specific molecular alterations that are …

Since 1984, when paclitaxel was approved by the FDA for the treatment of advanced
ovarian carcinoma, taxanes have been widely used as microtubule-targeting antitumor …

Autophagy is a highly conserved catabolic process that mediates degradation of pernicious
or dysfunctional cellular components, such as invasive pathogens, senescent proteins, and …

Autonomic nerve fibres in the tumour microenvironment regulate cancer initiation and
dissemination, but how nerves emerge in tumours is currently unknown. Here we show that …

Epithelial cell adhesion molecule (EpCAM) functions not only in physiological processes but
also participates in the development and progression of cancer. In recent decades …

Urological cancers have obtained much attention in recent years due to their mortality and
morbidity. The most common and malignant tumor of urological cancers is prostate cancer …

Prostate cancer (PCa) is a malignant disorder of prostate gland being asymptomatic in early
stages and high metastatic potential in advanced stages. The chemotherapy and surgical …

Abstract The PI3K/Akt/mTOR pathway has a central role in cancer metastasis and
radiotherapy. To develop effective therapeutics to improve radiosensitivity, understanding …

Programmed cell death (PCD) is probably the most widely discussed subject among the
topics of cancer therapy. Over the last 2 decades an astonishing boost in our perception of …

Background Inosine 5′-monophosphate dehydrogenase type II (IMPDH2) was originally
identified as an oncogene in several human cancers. However, the clinical significance and …